Meta Platforms will announce its fourth quarter earnings results today after the market closes. The upgraded 72 RS Rating means Meta stock is outperforming 72% of stocks in IBD's database on price performance. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
As the Fed raises interest rates, here are the biggest winners and losers from its latest decision.
The National Highway Traffic Safety Administration has revealed the root cause of the battery fires that halted Ford F-150 Lightning production.
The market's bubble has now "burst," and will impact "everything everywhere all at once" in the U.S. economy, economists Stephanie Pomboy and Art Laffer argue.
I am a 43-year-old divorced father. I have $315,000 in a traditional individual retirement account (IRA), $90,000 in a Roth IRA, $22,000 in a health savings account (HSA), $8,000 in a 529 college savings account, $30,000 in a traditional 401k, … Continue reading → The post Ask an Advisor: I'm a 43-Year-Old Divorced Dad With $315K in an IRA, $90K in a Roth and Other Accounts. Can I Retire at 57? appeared first on SmartAsset Blog.
Based on the average brokerage recommendation (ABR), NIO Inc. (NIO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
The legendary investor indicates that more than 60% of Comerica and U.S. Bancorp deposits are uninsured.
Elon Musk on late Monday offered his opinion on what the Federal Reserve should do with its benchmark interest rate. The Fed's FOMC is meeting for two days this week.
The last few weeks have been rocky, with the collapse of Silicon Valley Bank, and the crypto-heavy Silvergate and Signature banks, dominating the headlines. For a short time, it seemed that the contagion would spread to the global financial giants. Now, however, it appears that we’ve managed to avoid a true banking crisis – and Raymond James’ chief investment officer Larry Adam has pointed out several reasons why. For starters, Adam notes that Credit Suisse, despite its troubles, found a way out
Wolfe Research analyst Nigel Coe took a look at what GE Aerospace and GE Vernova will be worth on a stand-alone basis. GE Vernova, GE's power generation businesses, are due to be spun out in early 2024.
The Federal Reserve raised interest rates by another 0.25% on Wednesday as the central bank works to bring down elevated inflation while also grappling with the fallout from a global banking crisis and resulting market shocks.
U.S. stocks moved higher Wednesday after the Federal Reserve raised interest rates by quarter percentage point amid a fast-moving banking crisis.
The number of infections from the Candida Auris fungus, which can be deadly for people who are already sick, is small but rapidly growing.
Is the government doing more harm than good?
Airfare prices move up and down based on two major things -- passenger demand and the cost of actually flying the plane. Domestic air travel traffic for 2022 rose 10.9% compared to the prior year. The nation's air traffic in 2022 was at 79.6% of the full-year 2019 level.
The same dynamics that have left some banks reeling have handed taxpayers a windfall. The Fed will have to navigate them, David Beckworth writes.
The regional bank says it's not facing a bank run as investors fear risk of contagion after Silicon Valley Bank collapse.
The semiconductor stocks are outperforming the S&P 500 this year. Is it too late to get in?
Google’s artificial intelligence chatbot is still making the same error that contributed to a $120bn wipeout for the tech giant’s share price a month ago.
AbbVie Inc (NYSE: ABBV) provided a regulatory update on its New Drug Application (NDA) for ABBV-951 Wednesday morning. What To Know: AbbVie said it received a response from the U.S. Food and Drug Administration (FDA) on its NDA for the treatment of motor fluctuations in adults with advanced Parkinson's disease. The NDA is based on results from a Phase 3 clinical trial, which demonstrated statistically significant improvement in "On" time without troublesome dyskinesia compared to oral immediate-
UBS on Sunday agreed to buy rival Swiss bank Credit Suisse for 3 billion Swiss francs ($3.23 billion) in stock and agreed to assume up to 5 billion francs ($5.4 billion) in losses, in a shotgun merger engineered by Swiss authorities to avoid more market-shaking turmoil in global banking. Klein, a veteran dealmaker, was merging his eponymous advisory boutique into Credit Suisse's investment banking operations to create CS First Boston as a standalone business which he would have led from New York. UBS has now assigned a legal team to examine how to void the contract Credit Suisse signed with Klein in the cheapest way possible, according to the FT report, which cited people with direct knowledge of the matter.
Yahoo Finance 
Yahoo Finance Plus